Research Article
Laboratory Investigation (2008) 88, 98–111; doi:10.1038/labinvest.3700702; published online 3 December 2007
Functional and molecular interactions between the HGF/c-Met pathway and c-Myc in large-cell medulloblastoma
Yunqing Li1, Fadila Guessous1, Elizabeth B Johnson1, Charles G Eberhart2, Xiao-Nan Li3, Qing Shu3, Shongshan Fan4, Bachchu Lal6, John Laterra5,6, David Schiff1 and Roger Abounader1,7
- 1Department of Neurology, University of Virginia, Charlottesville, VA, USA
- 2Department of Pathology, The Johns Hopkins University, Baltimore, MD, USA
- 3Department of Pediatrics, Texas Children's Cancer Center, Baylor College of Medicine, Houston, TX, USA
- 4Department of Micro/Immunology, University of Rochester Medical Center, Rochester, NY, USA
- 5Department of Neurology, The Johns Hopkins University, Baltimore, MD, USA
- 6The Kennedy Krieger Research Institute, Baltimore, MD, USA
- 7Department of Microbiology, University of Virginia, Charlottesville, VA, USA
Correspondence: Dr R Abounader, MD, PhD, Department of Neurology, University of Virginia, Old Medical School, Room 4819, PO Box 800394, Charlottesville, VA 22908, USA. E-mail: ra6u@virginia.edu
Received 6 July 2007; Revised 25 October 2007; Accepted 26 October 2007; Published online 3 December 2007.
Abstract
The growth factor hepatocyte growth factor (HGF), also known as scatter factor, and its tyrosine kinase receptor c-Met play important roles in medulloblastoma malignancy. The transcription factor c-Myc is another contributor to the malignancy of these most common pediatric brain tumors. In the present study, we observed strong morphological similarities between medulloblastoma xenografts overexpressing HGF and medulloblastoma xenografts overexpressing c-Myc. We therefore hypothesized a biologically significant link between HGF/c-Met and c-Myc in medulloblastoma malignancy and studied the molecular and functional interactions between them. We found that HGF induces c-Myc mRNA and protein in established and primary medulloblastoma cells. HGF regulated c-Myc levels via transcriptional and post-transcriptional mechanisms as evidenced by HGF induction of c-Myc promoter activity and induction of c-Myc protein levels in the setting of inhibited transcription and translation. We also found that HGF induces cell cycle progression, cell proliferation, apoptosis and increase in cell size in a c-Myc-dependent manner. Activation of MAPK and PI3K, inhibition of GSK-3
and translocation of
-catenin to the nucleus as well as Tcf/Lef transcriptional activity were involved in mediating c-Myc induction by HGF. Induction of Cdk2 kinase activity was involved in mediating the cell cycle progression effects, and downregulation of Bcl-XL was involved in mediating the proapoptotic effects of HGF downstream of c-Myc. All molecules that mediated the effects of HGF on c-Myc expression, cell proliferation and apoptosis were expressed in human large-cell medulloblastoma tissues. We therefore established for the first time a functional cooperation between HGF/c-Met and c-Myc in human medulloblastoma and elucidated the molecular mechanisms of this cooperation. The findings provide a potential explanation for the high frequency of c-Myc overexpression in medulloblastoma and suggest a cooperative role for c-Met and c-Myc in large-cell anaplastic medulloblastoma formation.
Keywords:
c-Met, c-Myc, hepatocyte growth factor, scatter factor, medulloblastoma, embryonal CNS tumors
MORE ARTICLES LIKE THIS
These links to content published by NPG are automatically generated
REVIEWS
Drug development of MET inhibitors: targeting oncogene addiction and expedience
Nature Reviews Drug Discovery Review (01 Jun 2008)
RESEARCH
Gene Therapy Original Article
Bcr-Abl stabilizes β-catenin in chronic myeloid leukemia through its tyrosine phosphorylation
The EMBO Journal Article (07 Mar 2007)
Hepatocyte growth factor induces cell scattering through MAPK/Egr-1-mediated upregulation of Snail
The EMBO Journal Article (09 Aug 2006)
Cancer Gene Therapy Original Article

